Skip to main content
Joseph Rosenblatt, MD, Oncology, Miami, FL, Jackson Health System

JosephDRosenblattMD

Oncology Miami, FL

Professor of Medical Oncology, University Miami School of Medicine

Dr. Rosenblatt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rosenblatt's full profile

Already have an account?

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1983 - 1986
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1981 - 1983
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1980 - 1981
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1980

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1981 - Present
  • FL State Medical License
    FL State Medical License 2003 - 2026
  • NY State Medical License
    NY State Medical License 1995 - 2005
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2008-2014
  • America's Top Doctors for Cancer Castle Connolly, 2006-2013
  • Top Doctors:South Florida Castle Connolly, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • R-MACLO-IVAM Is an Effective Regimen to Induce Long Term Remission in Untreated Mantle Cell Lymphoma
    Joseph D. Rosenblatt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Sylvester Fuels Junior Faculty Members’ Research Careers with American Cancer Society Grants
    Sylvester Fuels Junior Faculty Members’ Research Careers with American Cancer Society GrantsMay 18th, 2023
  • Synergys Awarded NCI Grant to Develop SYN001 for Triple-Negative Breast Cancer
    Synergys Awarded NCI Grant to Develop SYN001 for Triple-Negative Breast CancerOctober 9th, 2017
  • SYNERGYS Announces Phase 1 SBIR Grant Award from National Institutes of Health
    SYNERGYS Announces Phase 1 SBIR Grant Award from National Institutes of HealthSeptember 26th, 2017
  • Join now to see all

Grant Support

  • Host Defense Regulation By HTLV-1National Cancer Institute2009–2011
  • Augmentation Of Anti-Tumor Activity In The Absence Of B CellsNational Cancer Institute2007–2011
  • HSV Amplicon Activation Of Innate And Adaptive ImmunityNational Cancer Institute2004–2008
  • Antibody Fusion Proteins For The Therapy Of CancerNational Cancer Institute2002
  • Chemokine Enhanced Immune Therapy Of LymphomaNational Cancer Institute2001–2002
  • Chemokine Enhanced Immune Therapy Of LymphomaNational Cancer Institute2000–2001
  • Antibody Fusion Proteins For The Therapy Of CancerNational Cancer Institute1999–2001
  • Inhibition Of HIV 1 Using A Mutant Trna PrimerNational Institute Of Allergy And Infectious Diseases1997–2000
  • Enhanced Immunogenicity Of Neuroblastoma Cells By Genetic EngineeringNational Cancer Institute1997–1998
  • Core--Gene And Cellular Therapy CoreNational Institute Of Allergy And Infectious Diseases1994–1997
  • Regulation Of Gene Expression In HTLV Type I/IINational Cancer Institute1990–1994
  • Pathogenesis Of HTLV-1 Associated MyelopathyNational Cancer Institute1990–1992
  • Pathogenic Mechanisms In HTLV-1 Linked DiseasesNational Cancer Institute1991
  • Role Of Novel X-Region Proteins In Htlv-1/11National Cancer Institute1987–1991

Hospital Affiliations